IMLFF - developing cannabis based therapies

Seite 1 von 1
neuester Beitrag:  25.04.21 02:59
eröffnet am: 13.01.17 19:35 von: JuExCa Anzahl Beiträge: 16
neuester Beitrag: 25.04.21 02:59 von: Angelikaxviga Leser gesamt: 12174
davon Heute: 8
bewertet mit 0 Sternen

13.01.17 19:35 #1 IMLFF - developing cannabis based therapies
InMed Pharmaceuticals Inc. is a biopharmaceutical company specializing in developing cannabis based therapies through the Research and Development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. The company is utilizing its proprietary Intelligent Cannabinoid Drug Design Platform "IDP" to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific diseases. Our extensive research and new intellectual properties will initially be focused on the development of several new cannabinoid based treatments for Ocular, Cancer, Inflammation, Pain & Arthritis disease areas.

http://www.otcmarkets.com/stock/IMLFF/profile

**********************************************

Four Long Term Penny Stock Picks For A Profitable 2017
Jan. 12, 2017 2:55 PM ET
http://seekingalpha.com/instablog/...enny-stock-picks-profitable-2017

**********************************************

A Short Term Play With 100% Gain Potential
December 10th, 2016
http://www.otcmarkets.net/short-term-alert/...ith-100-gain-potential/
Updated Target 01/13/2017 : 0.40  
13.01.17 19:37 #2 (persönlicher Startpreis) 0.235 USD
13.01.17 19:41 #3 Corporate Presentation - JAN 2017
14.01.17 08:35 #4 InMed Appoints Martin Bott to Board of Director.
InMed Pharmaceuticals Appoints Martin Bott to Board of Directors

PR Newswire
VANCOUVER, Jan. 13, 2017

CSE: IN
OTCQB: IMLFF

http://www.otcmarkets.com/stock/IMLFF/news/...ctors?id=148598&b=y  
16.01.17 22:31 #5 InMed heute an Heimatbörse mit neuem 52wk-hig.
17.01.17 20:08 #6 warum der kursanstieg?
was ist da heute an der nasdaq los?  
17.01.17 21:40 #7 Dundee Capital Markets Medical Marijuana Confer.
Jan. 17, 2017
Dundee Capital Markets: Medical Marijuana Conference
https://www.inmedpharma.com/investors/events/

 
21.01.17 18:35 #8 InMed Closes Non-Brokered Private Placement
InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,500,000

Jan. 18, 2017
https://www.inmedpharma.com/news-media/news/2017/...-for-c-1-500-000/  
24.01.17 12:15 #9 IMLFF - OTCQB Certification
IMLFF — OTCQB Certification

Published: Jan 23, 2017
http://www.otcmarkets.com/...lReportViewer?symbol=IMLFF&id=165456  
09.02.17 21:12 #10 IMLFF at 2017 BIO CEO & Investor Conference
InMed Pharmaceuticals to Present at the 2017 BIO CEO & Investor Conference

Feb. 9, 2017
http://www.tmxmoney.com/en/news/company_releases /news_full.html?file=201702091420CANADANWCANADAPR_C2972  
17.02.17 17:05 #11 Emerging AgroSphere ETF - including 'IMLFF'
16.03.17 15:15 #12 Publication of Discussion
NetworkNewsWire Announces Publication of Discussion on the R&D of Cannabinoids for Medical Use

Mar 16, 2017
http://web.tmxmoney.com/...wsid=6810111581391150&qm_symbol=IN:CNX  
05.04.17 18:56 #13 InMed an Heimatbörse mit neuem 52wk-high
12.05.17 16:15 #14 Patent Application for Ophthalmic Drug Delivery
InMed Pharmaceuticals Files Provisional Patent Application for Ophthalmic Drug Delivery

May 10, 2017
http://www.otcmarkets.com/stock/IMLFF/news/...ivery?id=158612&b=y  
13.09.17 14:29 #15 Prov.Patent for Biosynthesis of Cannabinoids
InMed Files Provisional Patent for Biosynthesis of Cannabinoids

Sep 12, 2017
http://www.otcmarkets.com/stock/IMLFF/news/...noids?id=169491&b=y  
10.01.19 17:46 #16 Cannabis-Werte derzeit gut Gefragt!
Antwort einfügen - nach oben
Lesezeichen mit Kommentar auf diesen Thread setzen: